157 related articles for article (PubMed ID: 26861804)
1. How breast cancer chemotherapy increases the risk of leukemia: Thoughts about a case of diffuse large B-cell lymphoma and leukemia after breast cancer chemotherapy.
Zhang B; Zhang X; Li M; Kong L; Deng X; Yu J
Cancer Biol Ther; 2016; 17(2):125-8. PubMed ID: 26861804
[TBL] [Abstract][Full Text] [Related]
2. Secondary hematological malignancies after breast cancer chemotherapy.
Park MJ; Park YH; Ahn HJ; Choi W; Paik KH; Kim JM; Chang YH; Ryoo BY; Yang SH
Leuk Lymphoma; 2005 Aug; 46(8):1183-8. PubMed ID: 16085560
[TBL] [Abstract][Full Text] [Related]
3. Pleomorphic mantle cell lymphoma mimicking diffuse large B-cell lymphoma in peripheral blood and bone marrow.
Ouseph M; Pinkus GS; Dorfman DM
Am J Hematol; 2019 Oct; 94(10):1170-1171. PubMed ID: 31004444
[No Abstract] [Full Text] [Related]
4. A diffuse large B cell lymphoma emerging with breast cancer relapse.
Karismaz A; Dogu MH; Huq G; Altindal S; Yokus O; Suyani E
Pan Afr Med J; 2018; 31():125. PubMed ID: 31037185
[TBL] [Abstract][Full Text] [Related]
5. Metachronous bilateral breast cancer diagnosed with primary breast lymphoma and mucinous carcinoma: The first case in the literature.
Simsek M; Aykas F; Yildirim AO
J Cancer Res Ther; 2022; 18(3):846-848. PubMed ID: 35900573
[TBL] [Abstract][Full Text] [Related]
6. Ipsilateral breast carcinoma following treatment for primary breast lymphoma.
Geffen DB; Cagnano E; Tokar M; Ariad S; Koretz M
Onkologie; 2007 Mar; 30(3):134-6. PubMed ID: 17341900
[TBL] [Abstract][Full Text] [Related]
7. Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer.
Valagussa P; Moliterni A; Terenziani M; Zambetti M; Bonadonna G
Ann Oncol; 1994 Nov; 5(9):803-8. PubMed ID: 7848882
[TBL] [Abstract][Full Text] [Related]
8. Primary diffuse large B cell lymphoma of the breast eight years after the diagnosis of gastric MALT lymphoma: report of first case.
Bilici A; Ozguroglu M; Tuzuner N; Goksel S; Turna H
Arch Gynecol Obstet; 2010 Nov; 282(5):587-90. PubMed ID: 20419308
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Suspected Therapy-Related Leukemia after Chemotherapy for Breast Cancer].
Yano Y; Kuga T; Harada T; Sano F; Inokuchi T; Fujii Y
Gan To Kagaku Ryoho; 2018 Dec; 45(12):1775-1777. PubMed ID: 30587740
[TBL] [Abstract][Full Text] [Related]
10. Synchronous bilateral primary breast lymphoma: MRI and pathologic findings.
Woo OH; Yong HS; Shin BK; Park CM; Kang EY
Breast J; 2007; 13(4):429-30. PubMed ID: 17593055
[No Abstract] [Full Text] [Related]
11. Breast cancer and leukemia: the forest for the trees?
Hudis C
Ann Surg Oncol; 2002 Oct; 9(8):717-8. PubMed ID: 12374652
[No Abstract] [Full Text] [Related]
12. Secondary bone marrow malignancies after adjuvant chemotherapy for breast cancer: a report of 2 cases and a review of the literature.
Rossi D; Sarti D; Malerba L; Tommasoni S; Visani G; Martignetti A; Fiorentini G
Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26979247
[TBL] [Abstract][Full Text] [Related]
13. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
Diamandidou E; Buzdar AU; Smith TL; Frye D; Witjaksono M; Hortobagyi GN
J Clin Oncol; 1996 Oct; 14(10):2722-30. PubMed ID: 8874333
[TBL] [Abstract][Full Text] [Related]
14. Diffuse large B-cell lymphoma in leukemic phase.
Hazarika B
Blood; 2014 Sep; 124(13):2159. PubMed ID: 25379600
[No Abstract] [Full Text] [Related]
15. Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation.
Kröger N; Zander AR; Martinelli G; Ferrante P; Moraleda JM; Da Prada GA; Demirer T; Socie G; Rosti G;
Ann Oncol; 2003 Apr; 14(4):554-8. PubMed ID: 12649100
[TBL] [Abstract][Full Text] [Related]
16. Primary testicular lymphoma.
Lobo FD; Bansal R; Naik R; Pai MR; Dinesh D
J Indian Med Assoc; 1998 Jun; 96(6):193-4. PubMed ID: 9834575
[No Abstract] [Full Text] [Related]
17. Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group.
Campone M; Roché H; Kerbrat P; Bonneterre J; Romestaing P; Fargeot P; Namer M; Monnier A; Montcuquet P; Goudier MJ; Fumoleau P
Ann Oncol; 2005 Aug; 16(8):1343-51. PubMed ID: 15905306
[TBL] [Abstract][Full Text] [Related]
18. Diffuse large B-cell non-Hodgkin's lymphoma presenting as a vaginal mass in a patient with a history of intestinal mucosa-associated lymphoid tissue (MALT) lymphoma.
Hosing C; Freedman RS; McLaughlin P; Malpica A; Fornage BD; Kudelka AP
Am J Clin Oncol; 2001 Apr; 24(2):204-8. PubMed ID: 11319299
[TBL] [Abstract][Full Text] [Related]
19. Breast lymphoma occurring after an invasive ductal breast carcinoma developed in the same area: A case report and literature review.
Demoor-Goldschmidt C; Mahé MA; Supiot S
Cancer Radiother; 2018 Apr; 22(2):167-170. PubMed ID: 29657120
[TBL] [Abstract][Full Text] [Related]
20. Three cases of malignant lymphoma of the breast.
Suzuki Y; Tokuda Y; Okumura A; Saito Y; Ohta M; Kubota M; Makuuchi H; Tajima T; Umemura S; Osamura RY
Jpn J Clin Oncol; 2000 Jan; 30(1):33-6. PubMed ID: 10770567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
